Results 211 to 220 of about 29,828 (259)
Some of the next articles are maybe not open access.
Cochrane Database of Systematic Reviews, 2007
For many years amitriptyline has been considered one of the reference compounds for the pharmacological treatment of depression. However, new tricyclic drugs, heterocyclic compounds and selective serotonin reuptake inhibitors have been introduced on the market with the claim of a more favourable tolerability/efficacy profile.The aim of the present ...
G, Guaiana, C, Barbui, M, Hotopf
openaire +2 more sources
For many years amitriptyline has been considered one of the reference compounds for the pharmacological treatment of depression. However, new tricyclic drugs, heterocyclic compounds and selective serotonin reuptake inhibitors have been introduced on the market with the claim of a more favourable tolerability/efficacy profile.The aim of the present ...
G, Guaiana, C, Barbui, M, Hotopf
openaire +2 more sources
Chronopharmacology of amitriptyline
Clinical Pharmacology and Therapeutics, 1983Side effects of decreased salivation and sedation were more marked when a single dose of amitriptyline was taken orally in the morning than in the evening. These dynamic differences were due to alteration in kinetics. Absorption of the drug was more rapid in the morning, although other kinetic parameters, especially total bioavailability, were ...
S, Nakano, L E, Hollister
openaire +2 more sources
Amitriptyline and Amitriptyline-with-Perphenazine in Depression—A Retrospective Study
British Journal of Psychiatry, 1967The object of this paper is to assess, in retrospect, the relative effectiveness of amitriptyline (‘Triptizol’) and amitriptyline with perphenazine (‘Triptafen’) in the treatment of depressed patients.
C, Chacón, E T, Downham
openaire +2 more sources
Classics in Chemical Neuroscience: Amitriptyline
ACS Chemical Neuroscience, 2021R Nathan Daniels
exaly
Amitriptyline and somnambulism
The Annals of Pharmacotherapy, 2000Juan A Ferrándiz-Santos +1 more
openaire +1 more source